false 0001099219 0001099219 2019-12-11 2019-12-11 0001099219 us-gaap:CommonStockMember 2019-12-11 2019-12-11 0001099219 us-gaap:SeriesAMember 2019-12-11 2019-12-11 0001099219 us-gaap:SeriesEPreferredStockMember 2019-12-11 2019-12-11

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): December 11, 2019

METLIFE, INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

1-15787

 

13-4075851

     

(Commission File Number)

 

(IRS Employer Identification No.)

     

200 Park Avenue, New York, New York

10166-0188

     

(Address of Principal Executive Offices)

 

(Zip Code)

212-578-9500

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.01

 

 

MET

 

 

New York Stock Exchange

 

Floating Rate Non-Cumulative Preferred Stock, Series A, par value $0.01

 

 

MET PRA

 

 

New York Stock Exchange

 

Depositary Shares each representing a 1/1000th interest in a share of 5.625% Non-Cumulative Preferred Stock,
Series E

 

 

MET PRE

 

 

New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  


Item 7.01 Regulation FD Disclosure.

The slide presentation attached hereto as Exhibit 99.1, and incorporated herein by reference, will be presented at MetLife, Inc.’s investor conference on December 12, 2019 and may be used by MetLife, Inc. in various other presentations to investors. The slide presentation is furnished as of December 11, 2019 but not filed, pursuant to Instruction B.2 of Form 8-K.

Item 9.01 Financial Statements and Exhibits.
         
 

99.1

   

Outlook slide presentation to be presented at MetLife, Inc.’s investor conference on December 12, 2019.

         
 

101

   

Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

         
 

104

   

The cover page from this Current Report on Form 8-K, formatted as Inline XBRL.

2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

METLIFE, INC.

     

By:

 

/s/ Tamara Schock

 

Name: Tamara Schock

 

Title: Executive Vice President and

Chief Accounting Officer

Date: December 11, 2019

3